IL1B and melanoma: To further validate the functional relevance of tumor-enriched populations, we performed IL-1β-enriched NT GSDMD treatment of B16F10 melanoma in immunocompetent C57BL/6 mice with depleted NK1.1 and CD8β-expressing cells.